Borgeson Blake
Reporting owner on Forms 3, 4 and 5, CIK 1856094.
Borgeson Blake reported on 1 issuer in 1 filing, the latest a Form 4 filed 2026-10-07.
Issuers
| Issuer | Roles in the latest filing | Filings | Last filed |
|---|---|---|---|
| RXRX · RECURSION PHARMACEUTICALS, INC.CIK 1601830 | director | 1 | 2026-10-07 |
Transactions and holdings
Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.
| Security | Date | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| RXRX · RECURSION PHARMACEUTICALS, …Class A Common Stock | 2026-10-06 | S sold | -50,000 | $4.84 | 6,108,287 | Form 4 |
Filings
The person's Forms 3, 4 and 5, and any 13D or 13G naming it.
| Filing | Subject | Filed | Accepted | Ingested |
|---|---|---|---|---|
| Form 4 0001601830-26-000120 | RECURSION PHARMACEUTICALS, INC. | 2026-10-07 |